Olokizumab reduces the risks of death in hospitalized patients with moderate and severe COVID-19
Tavlueva, E.V., Markarov, A.E., Petrushin, M.A., Vizel, A.A., Ignatova, G.L., Antonov, V.N., Agaf'ina, A.S., Bakirov, B.A., Mozgovaya, V.M., Filon, O.V., Zinkovskaya, A.V., Dolgorukova, A.N., Samsonov, M.Yu
Published in Infectious diseases: News, Opinions, Training (2022)
Published in Infectious diseases: News, Opinions, Training (2022)
Get full text
Journal Article
Efficacy and safety of 8-week combination therapy for chronic hepatitis C with protease inhibitor narlaprevir
Gusev, D.A., Klimova, E.А., Znoyko, O.O., Isakov, V.A., Kropochev, V.S., Zhdanov, K.V., Kizhlo, S.N., Kozlov, K.V., Sukachev, V.S., Batskikh, S.N., Tarkhova, E.P., Krasavina, E.N., Samsonov, M.Yu, Yushchuk, N.D.
Published in Infectious diseases: News, Opinions, Training (2020)
Published in Infectious diseases: News, Opinions, Training (2020)
Get full text
Journal Article
Narlaprevir, ritonavir, and sofosbuvir in non-cirrhotic chronic hepatitis C genotype 1 infected patients
Klimova, E.А., Znoyko, O.O., Chulanov, V.P., Gusev, D.A., Isakov, V.A., Zhdanov, K.V., Batskikh, S.N., Kizhlo, S.N., Mamonova, N.A., Kozlov, K.V., Sukachev, V.S., Tarkhova, E.P., Krasavina, E.А., Samsonov, M.Yu, Yushchuk, N.D.
Published in Infectious diseases: News, Opinions, Training (2020)
Published in Infectious diseases: News, Opinions, Training (2020)
Get full text
Journal Article
Safety and efficacy of nemonoxacin versus levofloxacin in the treatment of community-acquired pneumonia: results of phase III, multicenter, randomized, double-blind, active-controlled, non-inferiority trial
Kozlov, R.S., Dekhnich, А.V., Zaitsev, А.А., Nilk, R.Ya, Samsonov, М.Yu, Berezhanskiy, B.V., Salazanov, D.А
Published in Klinicheskai︠a︡ mikrobiologii︠a︡ i antimikrobnai︠a︡ khimioterapii︠a (01.11.2018)
Published in Klinicheskai︠a︡ mikrobiologii︠a︡ i antimikrobnai︠a︡ khimioterapii︠a (01.11.2018)
Get full text
Journal Article